References
- Spina GP, Arcidiacono R, Bosch J, et al. Gastric endoscopic features in portal hypertension: final report of a consensus conference, Milan, Italy, September 19, 1992. J Hepatol. 1994;21(3):461–467.
- Lemmers A, Evrard S, Demetter P, et al. Gastrointestinal polypoid lesions: a poorly known endoscopic feature of portal hypertension. United Eur Gastroenterol J. 2014;2(3):189–196.
- Zaman A, Hapke R, Flora K, et al. Prevalence of upper and lower gastrointestinal tract findings in liver transplant candidates undergoing screening endoscopic evaluation. Am J Gastroenterol. 1999;94(4):895–899.
- Héroin L, Saviano A, Fenouil T, et al. Differences between sporadic hyperplastic gastric polyps and portal hypertensive gastric polyps: a review. Eur J Gastroenterol Hepatol. 2022;34(3):260–266.
- Kara D, Husing-Kabar A, Schmidt H, et al. Portal hypertensive polyposis in advanced liver cirrhosis: the unknown entity? Can J Gastroenterol Hepatol. 2018;2018:1–7.
- Nagpal SJ, Macaron C, Pai RK, et al. Gastric polyposis: a rare cause of iron deficiency anemia in a patient with portal hypertension. ACG Case Rep J. 2015;2(2):89–91.
- Panackel C, Joshy H, Sebastian B, et al. Gastric antral polyps: a manifestation of portal hypertensive gastropathy. Indian J Gastroenterol. 2013;32(3):206–207.
- Lee TH, Jang JY, Jeong SW, et al. Gastric polyposis associated with portal hypertension. Korean J Intern Med. 2013;28(2):261.
- Lam MC, Tha S, Owen D, et al. Gastric polyps in patients with portal hypertension. Eur J Gastroenterol Hepatol. 2011;23(12):1245–1249.
- Topal F, Akbulut S, Karahanlı C, et al. Portal hypertensive polyps as gastroscopic finding in liver cirrhosis. Gastroenterol Res Pract. 2020;2020:9058909.
- Amarapurkar AD, Amarapurkar D, Choksi M, et al. Portal hypertensive polyps: distinct entity. Indian J Gastroenterol. 2013;32(3):195–199.
- Zimmer V, Emrich K. Nodular gastric antral vascular ectasia: Distinct portal hypertensive hyperplastic polyp lesions. Clin Res Hepatol Gastroenterol. 2022;46(1):101745.
- Lenz A, Haynes A, Limacher A. Presize: precision based sample size calculation. R package version 0.1.3. 2020. Available from: https://CRAN.R-project.org/package=presize
- Brown L, Cai T, DasGupta A. Interval estimation for a binomial proportion. Stat Sci. 2001;16(2):101–117.
- Wilson EB. Probable inference, the law of succession, and statistical inference. J Am Stat Assoc. 1927;22(158):209–212.
- Team RC. R: a language and environment for statistical computing. R Foundation for Statistical Computing. 2020.
- van Buuren S, Groothuis-Oudshoorn K. Mice: multivariate imputation by chained equations in R. J Stat Softw. 2011;45(3):1–67.
- Du J, Boss J, Han P, et al. Variable selection with multiply-imputed datasets: choosing between stacked and grouped methods. arXiv preprint arXiv:200307398. 2020.
- Rubin DB. Multiple imputation for nonresponse in surveys. New York: John Wiley & Sons, Inc; 1987.
- Boyd JT, Lee L. Portal hypertension-associated gastric polyps. BMJ Case Rep. 2014;2014. DOI:https://doi.org/10.1136/bcr-2013-202312
- Zaman A, Hapke R, Flora K, et al. Prevalence of upper and lower gastrointestinal tract findings in liver transplant candidates undergoing screening endoscopic evaluation. Am J Gastroenterol. 1999;94(4):895–899.
- De Lisi S, Peralta S, Arini A, et al. Oesophagogastroduodenoscopy in patients with cirrhosis: extending the range of detection beyond portal hypertension. Dig Liver Dis. 2011;43(1):48–53.
- Vizzutti F, Arena U, Romanelli RG, et al. Liver stiffness measurement predicts severe portal hypertension in patients with HCV-related cirrhosis. Hepatology. 2007;45(5):1290–1297.
- Bureau C, Metivier S, Peron JM, et al. Transient elastography accurately predicts presence of significant portal hypertension in patients with chronic liver disease. Aliment Pharm Ther. 2008;27(12):1261–1268.
- Lemoine M, Katsahian S, Ziol M, et al. Liver stiffness measurement as a predictive tool of clinically significant portal hypertension in patients with compensated hepatitis C virus or alcohol-related cirrhosis. Aliment Pharmacol Ther. 2008;28(9):1102–1110.
- Llop E, Berzigotti A, Reig M, et al. Assessment of portal hypertension by transient elastography in patients with compensated cirrhosis and potentially resectable liver tumors. J Hepatol. 2012;56(1):103–108.
- Villanueva C, Albillos A, Genesca J, et al. β blockers to prevent decompensation of cirrhosis in patients with clinically significant portal hypertension (PREDESCI): a randomised, double-blind, placebo-controlled, multicentre trial. Lancet. 2019;393(10181):1597–1608.
- Ekelund M, Håkanson R, Holmin T, et al. Effects of portacaval shunt on the rat stomach. Acta Physiol Scand. 1985;124(3):437–447.
- Sigounas DE, Shams A, Hayes PC, et al. Endoscopic ultrasound assessment of gastrointestinal polypoid lesions of indeterminate morphology in patients with portal hypertension. Endosc Int Open. 2018;6(3):E292–E9.
- Yasugi K, Haruma K, Kawanaka M, et al. Disappearance of gastric hyperplastic polyps after the discontinuation of proton pump inhibitor in a patient with liver cirrhosis. Case Rep Gastroenterol. 2021;15(1):202–209.